Skip to main content
Log in

Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review)

  • Search for New Drugs
  • Published:
Pharmaceutical Chemistry Journal Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. Morb Mortal Wkly Rep., 48, 1–28 (1999).

  2. V. Uchaikin, Med. Gazeta, No. 10 (1997).

  3. É. Kil’burn, Influenza: Virus and Disease [Russian translation], Meditsina, Moscow (1978), pp. 309–351.

    Google Scholar 

  4. L. Kaiser, R. Couch, G. Galasso, et al., Antiviral. Res., 42(3), 149–176 (1999).

    Google Scholar 

  5. J. De Jong, E. Claas, A. Osterhaus, et al., Nature, 389(6651), 554 (1997).

    Article  Google Scholar 

  6. M. Peiris, K. Yuen, C. Leung, et al., Lancet, 354(9182), 916–917 (1999).

    Google Scholar 

  7. T. Tran, T. Nguyen, T. Nguyen, et al., N. Eng. J. Med., 350, 1179–1188 (2004).

    Google Scholar 

  8. F. Ruben, Inf. Dis. Clin. North Am., 4, 1–10 (1990).

    Google Scholar 

  9. T. Bektimirov, Byull. Vaktsin., 27, 1–5 (2003).

    Google Scholar 

  10. R. Lamb, C. Lai, and P. Choppin, Proc. Natl. Acad. Sci. U. S. A., 78(7), 4170–4174 (1981).

    Google Scholar 

  11. A. Hay, in: Antiviral Drug Resistance, D. Richman (ed.), John Willey and Sons Ltd., Chichester, UK (1996), pp. 44–58.

    Google Scholar 

  12. W. Davies, R. Grunert, R. Haff, et al., Science, 144, 862–863 (1964).

    Google Scholar 

  13. A. Smorodintsev, D. Zlydnikov, A. Kiseleva, et al., J. Am. Med. Assoc., 213(9), 1448–1454 (1970).

    Google Scholar 

  14. T. Jefferson, V. Demicheli, J. Deeks, et al, in: The Cochraine Library, John Wiley & Sons Ltd., Chichester, UK (2004), Issue 1.

    Google Scholar 

  15. F. Marra, C. Marra and H. Stiver, Can. Resp. J., 10, 381–388 (2003).

    Google Scholar 

  16. F. Hayden, R. Belshe, R. Clover, et al., N. Eng. J. Med., 281, 579–584 (1989).

    Google Scholar 

  17. R. Belshe, B. Burk, F. Newman, et al., J. Inf. Dis., 159(3), 430–435 (1989).

    Google Scholar 

  18. K. Nicholson and M. Wiselka, Br. Med. J., 302(6774), 425–426 (1991).

    Google Scholar 

  19. L. Van Voris, R. Betts, F. Hayden, et al., J. Am. Med. Assoc., 245(11), 1128–1131 (1981).

    Google Scholar 

  20. R. Dolin, R. Reichman, H. Madore, et al., N. Eng. J. Med., 307, 580–584 (1982).

    Google Scholar 

  21. V. Horadam, J. Sharp, and J. Smilack, Annals Int. Med., 94, 454–458 (1981).

    Google Scholar 

  22. R. Tominack, R. Willis, L. Gustavson, et al., Antimicrob. Agents Chemother., 32(3), 1813–1819 (1988).

    Google Scholar 

  23. P. Palese and J. Shulman, in: Chemoprophylaxis and Virus infections of the Respiratory Tract, J. S. Oxford (ed.), CRC Press, Cleveland (1977), Vol. 1, pp. 189–205.

    Google Scholar 

  24. M. von Itzstein, W.-Y. Wu, G. Kok, et al., Nature, 363(6428), 418–423 (1993).

    Article  PubMed  Google Scholar 

  25. J. Woods, R. Bethell, J. Coates, et al., Antimicrob. Agents Chemother., 37(3), 1473–1479 (1993).

    Google Scholar 

  26. D. Ryan, J. Ticehurst, M. Dempsey, et al., Antimicrob. Agents Chemother., 38(4), 2270–2275 (1994).

    Google Scholar 

  27. F. Hayden, A. Osterhaus, J. Treanor, et al., N. Eng. J. Med., 337, 874–880 (1997).

    Google Scholar 

  28. D. Calfee, A. Preng, E. Hussey, et al., Antivir. Ther., 4(3), 143–149 (1999).

    Google Scholar 

  29. A. Monto, D. Robinson, L. Herlocher, et al., J. Am. Med. Assoc., 282(1), 31–35 (1999).

    Google Scholar 

  30. The MIST Study Group, Lancet, 352, 1877–1881 (1998).

    Google Scholar 

  31. A. Monto, D. Fleming, and D. Henry, J. Infect. Dis., 180(2), 254–261 (1999).

    Google Scholar 

  32. J. Lazelari, K. Campion, O. Keene, et al., Arch. Int. Med., 161, 212–217 (2001).

    Google Scholar 

  33. K. Murphy, A. Eivindson, K. Paukens, et al., Clin. Drug Invest., 20, 337–349 (2000).

    Google Scholar 

  34. N. Cooper, A. Sutton, K. Abrams, et al., Br. Med. J., 326(7401), 1235 (2003).

    Google Scholar 

  35. J. Treanor, F. Hayden, P. Vrooman, et al., J. Am. Med. Assoc., 283(8), 1016–1024 (2000).

    Google Scholar 

  36. F. Aoki, M. Macleod, P. Paggiaro, et al., Antimicrob. Agents Chemother., 51(1), 123–129 (2003).

    Google Scholar 

  37. D. Mendel and R. Sidwell, Drug Resist. Updates, 1, 184–189 (1998).

    Google Scholar 

  38. J. McKimm-Breshkin, T. Trivedi, A. Hampson, et al., Antimicrob. Agents Chemother., 47(7), 2264–2272 (2003).

    Google Scholar 

  39. D. Smee and R. Sidwell, Expert Opinion Investig. Drugs, 1, 859–869 (2002).

    Google Scholar 

  40. RF Patent No. 2033156; Byull. Izobret., No. 11 (1995).

  41. RF Patent No. 2008004; Byull. Izobret., No. 14 (1994).

  42. R. Glushkov, Drug of the Future, 17, 1079–1081 (1992).

    Google Scholar 

  43. T. A. Gus’kova, Abstracts of Papers. The 2nd All-Russia Congr. “Humans and Drugs” [in Russian], Moscow (1995), p. 188.

  44. T. A. Gus’kova and R. G. Glushkov, Arbidol: Immunostimulant, Interferon Inductor, and Antioxidant [in Russian], Timotek, Moscow (1999).

    Google Scholar 

  45. I. S. Nikolaeva and T. A. Guskova, Abstracts of Papers. The 18th Int. Congr. on Chemotherapy, Stockholm (1993), Abstr. 190.

  46. T. A. Guskova, I. S. Nikolaeva, and N. G. Zacharova, Abstracts of Papers. The 9th Mediter. Congr. on Chemotherapy, Athens (1994), Abstr. 82.

  47. I. A. Leneva, N. I. Fadeeva, I. T. Fedyakina, et al., Khim.-Farm. Zh., 28(9), 4–8 (1994).

    Google Scholar 

  48. R. G. Glushkov, N. I. Fadeeva, I. A. Leneva, et al., Khim.-Farm. Zh., 26(2), 8–15 (1992).

    Google Scholar 

  49. N. I. Fadeeva, I. A. Leneva, E. K. Panisheva, et al., Khim.-Farm. Zh., 26(9), 9–11 (1992).

    Google Scholar 

  50. I. Leneva and A. Hay, Abstracts of Papers. The 12th Congr. on Virology, Paris (2002), Abstr. 1077.

  51. O. I. Kubar’, Abstracts of Papers. The Jubilee Conf. of the Pasteur Institute (St. Peterstburg), St. Petersburg (1993), pp. 9–11.

  52. L. V. Feklisova, V. M. Shebekova, A. N. Slepushkin, et al., Nov. Lek. Prep., No. 3, 19–22 (1995).

  53. N. P. Obrosova-Serova, E. N. Burtseva, I. M. Nevskii, et al., Vopr. Virusol., 5, 380–381 (1991).

    Google Scholar 

  54. E. Burtseva, A. Beljaev, A. Sominina, et al., Abstracts of Papers. The 3th Asia-Pacific Congr. on Medical Virology, Beijing, China (1994).

  55. A. A. Beljaev, E. N. Burtseva, A. E. Slepushkin, et al., Vestn. Ross. Akad. Med. Nauk., No. 4, 34–37 (1996).

  56. O. I. Kubar’, L. A. Stepanova, L. S. Safonova, et al., Abstracts of Papers. The 4th All-Russia Congr. “Humans and Drugs” [in Russian], Moscow (1997), p. 269.

  57. T. A. Gus’kova, Toxicology of Drugs [in Russian], Russkii Vrach, Moscow (2003), p. 103.

    Google Scholar 

  58. T. A. Guskova and L. Yu. Krylova, Can. J. Inf. Dis., 6, 456 (1995).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 38, No. 11, pp. 8 – 14, November, 2004.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leneva, I.A., Glushkov, R.G. & Gus’kova, T.A. Drugs for chemotherapy and prophylaxis of influenza: Mechanisms, efficacy, and safety (a review). Pharm Chem J 38, 590–596 (2004). https://doi.org/10.1007/s11094-005-0036-9

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-005-0036-9

Keywords

Navigation